Elsevier

European Journal of Cancer

Volume 36, Issue 13, August 2000, Pages 1607-1620
European Journal of Cancer

The E-cadherin–catenin complex in tumour metastasis: structure, function and regulation

https://doi.org/10.1016/S0959-8049(00)00158-1Get rights and content

Abstract

E-cadherin and the associated catenin complex have been recognised as performing a key role in cell adhesion. Loss of cell adhesion is seen as a key step in the cascade leading to tumour metastasis. The ability of both extra- and intracellular factors to regulate E-cadherin-mediated cell adhesion in physiological processes has provided insight into both the interactions of the E-cadherin–catenin complex, and possible mechanisms utilised by tumours in the process of metastasis. The interaction of the E-cadherin–catenin complex with various regulating factors, their effect on cell signalling pathways, and the relationship with the metastatic potential of tumours are reviewed.

Introduction

Since it was first recognised that tumours had the ability to invade adjacent tissues and spread to distant organs, extensive research has been performed, expanding the body of knowledge on this basic hallmark of malignancy. In recent years, with the advent of molecular techniques, crucial insights into the interplay of various factors at a molecular and genetic level have been gained. The resultant model shows metastasis to be a co-ordinated multi-step process encompassing the detachment of cells from the primary tumour to the development of a tumorigenic lesion at a distant site 1, 2.

The process of metastasis appears to be regulated by a variety of gene products. These include cell–cell and cell–extracellular matrix receptors 3, 4; proteolytic enzymes that facilitate breakdown and invasion of the basement membrane, vascular channels and organs 5, 6, 7; motility factors which allow migration through tissues 8, 9; receptors mediating organ-specific invasion [10]; growth factors necessary for the maintenance of the tumour microcolonies in the secondary organ [11]; and angiogenic factors that result in neovascularisation of the metastasis, allowing the supply of nutrients, removal of metabolites and haematogenous spread of metastatic cells 12, 13. Weakening of cell–cell adhesion is obviously imperative for tumour cells to metastasise. In recent years, several families of biochemically and genetically distinct cell adhesion molecules have been described. These include the cadherins, integrins, adhesion molecules belonging to the immunoglobulin superfamily, selectins and cell-determinant CD44.

The role of E-cadherin in metastasis has become topical in the past few years due to its apparent promise as a prognostic indicator, with loss or reduction of expression correlating with enhanced aggressiveness and dedifferentiation of many carcinomas 14, 15, 16, 17, 18, 19. Some tumours also display the ability to regulate E-cadherin expression during the process of metastasis, which raises questions about the role of the tumour microenvironment [20]. It has recently been hypothesised that hypoxia within tumours, resulting in tumour necrosis, causes downregulation of E-cadherin, and ultimately sets the metastatic cascade in motion [21]. In this paper, the interactions of the E-cadherin–catenin complex with various regulating factors, the consequences of the interactions on cell signalling pathways, and the relationship with the metastatic potential of tumours will be reviewed.

Section snippets

The E-cadherin–catenin complex

The cadherin family consists of transmembrane glycoproteins responsible for calcium-dependent cell adhesion. The family is widespread in normal tissues but the individual members display pronounced tissue specificity. E-cadherin is one of the members of the family and is present within epithelial cells, where it tends to localise to specialised junctions of the zonula adherens type 22, 23.

The human E-cadherin gene (CDH1) is situated on chromosome 16q22.1, within a large conserved-linkage group

Regulation of E-cadherin by interactions with the E-cadherin–catenin complex in non-transformed cells

Regulation of E-cadherin expression can occur in both physiological and pathological settings. Variations in E-cadherin expression have been noted during specific events in embryonic morphogenesis 64, 65. An example of such a process is during the development of the murine cochlea, where E-cadherin is downregulated on the lateral membranes of the reticular lamina, allowing the process of fluid space opening in the organ of Corti [66]. Embryonic processes have become important in providing

Regulation of E-cadherin in malignant cells

The E-cadherin–catenin complex, that mediates cell adhesion, is dependent on numerous interactions that have been highlighted above. Thus, it should be obvious that cell adhesion is not solely dependent on the structural and functional integrity of the E-cadherin molecule but also that of the associated catenins and other molecules that mediate its binding to the cytoskeleton. Reduction in cell adhesion is of major importance in tumour metastasis and appears to be achieved by a variety of

The role of hypoxia in E-cadherin regulation and metastasis

It is clear that factors external to the cell have a major influence on cell adhesion. The milieu in which the transformed cells of malignant tumours exist is bound to be very different from that found in normal tissues. By their very nature, malignant tumours act to create an environment that aids their transformation and progression. Growth by cellular proliferation is the main function of malignant tumours and it occurs at the expense of all other cellular activities. The disorganised

Conclusion

It has been demonstrated that the control of E-cadherin-mediated cell adhesion in benign and malignant epithelial cells is complex and relies on interactions between various external factors and intracellular signalling pathways. The loss or downregulation of E-cadherin is a key event in the process of tumour invasion and metastasis. As understanding of the interactions involving components of the E-cadherin system increases, hopefully so will the ability to predict and combat these events,

The outstanding questions

  • What is the true role of p120ctn in cell adhesion?

  • What is the pathway through which E-cadherin stimulates contact adhesion and does it have a role in tumour progression?

  • Does EGFR stimulation have an effect on the small GTPases, possibly through an interaction with GAP?

  • Can E-cadherin downregulation be blocked?

  • Does hypoxia initiate the metastatic cascade?

  • Does tirapazamine have a role to play in the prevention of metastasis?

Acknowledgements

The author thanks Professor K.S.O. Beavon for critical reading of this manuscript and Mrs V. Wiseman for the preparation of the illustrations.

References (204)

  • A. Nose et al.

    Localization of specificity determining sites in cadherin cell adhesion molecules

    Cell

    (1990)
  • A.S. Yap et al.

    Lateral clustering of the adhesive ectodomaina fundamental determinant of cadherin function

    Curr Biol.

    (1997)
  • B.Z. Katz et al.

    Modulation of cell-cell adherens junctions by surface clustering of the N-cadherin cytoplasmic tail

    Exp Cell Res.

    (1998)
  • C.L. Adams et al.

    Cytomechanics of cadherin-mediated cell–cell adhesion

    Curr. Opin. Cell Biol.

    (1998)
  • E. Provost et al.

    Controversies at the cytoplasmic face of cadherin-based adhesion complex

    Curr. Opin. Cell Biol.

    (1999)
  • P.D. McCrea et al.

    Purification of a 92-kDa cytoplasmic protein tightly associated with the cell–cell adhesion molecule E-cadherin (uvomorulin). Characterization and extractability of the protein complex from the cell cytostructure

    J. Biol. Chem.

    (1991)
  • J.D. McPherson et al.

    Assignment of the human alpha-catenin gene (CTNNA1) to chromosome 5q21-22

    Genomics

    (1994)
  • C. Kraus et al.

    Localization of the human β-catenin gene (CTNNB1) to 3p21a region implicated in tumor development

    Genomics

    (1994)
  • A.B. Reynolds et al.

    The gene encoding p120cas, a novel catenin, localizes on human chromosome 11q11 (CTNND) and mouse chromosome 2 (Catns)

    Genomics

    (1996)
  • S. Butz et al.

    Distinct cadherin/catenin complexes in Ca (2+)-dependent cell–cell adhesion

    FEBS Lett.

    (1994)
  • I. Reima et al.

    The cytoskeleton and associated proteins during cleavage, compaction and blastocyst differentiation in the pig

    Differentiation

    (1993)
  • J. Van Aken et al.

    Immunohistochemical analysis of E-cadherin expression in human colorectal tumours

    Pathol Res Pract

    (1993)
  • N. Sakuragi et al.

    Decreased E-cadherin expression in endometrial carcinoma is associated with tumor dedifferentiation and deep myometrial invasion

    Gynecol Oncol

    (1994)
  • M. Mareel

    De Baetselier P, Van Roy, F. Mechanisms of Invasion and Metastasis

    (1991)
  • L.R. Bernstein et al.

    Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis

    Curr. Opin. Oncol.

    (1994)
  • V. Ellis et al.

    The urokinase receptorinvolvement in cell surface proteolysis and cancer invasion

    Ann. NY Acad. Sci.

    (1992)
  • L.A. Liotta

    Cancer cell invasion and metastasis

    Sci. Am.

    (1992)
  • L.M. Matrisian

    The matrix-degrading metalloproteinases

    Bioessays

    (1992)
  • G.L. Nicolson

    Molecular mechanisms of cancer metastasistumor and host properties and the role of oncogenes and suppressor genes

    Curr. Opin. Oncol.

    (1991)
  • J. Folkman

    Angiogenesis in cancer, vascular, rheumatoid and other disease

    Nature Med.

    (1995)
  • M. Mareel et al.

    Invasion promoter versus invasion suppressor moleculesthe paradigm of E-cadherin

    Mol. Biol. Rep

    (1994)
  • M. Takeishi

    Cadherins in cancerimplications for invasion and metastasis

    Curr. Opin. Cell Biol.

    (1993)
  • Y. Shino et al.

    Clinicopathologic evaluation of immunohistochemical E-cadherin expression in human gastric carcinomas

    Cancer

    (1995)
  • S. Tamura et al.

    Decreased E-cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus

    Br. J. Surg.

    (1996)
  • N.C.A. Hunt et al.

    Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas

    Vichows Arch

    (1997)
  • I.K. Bukholm et al.

    Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not gamma-catenin, in metastatic tissue from breast cancer patients

    J. Pathol.

    (2000)
  • I.R.G. Beavon

    Regulation of E-cadherindoes hypoxia initiate the metastatic cascade?

    J. Clin. Pathol.Mol. Pathol.

    (1999)
  • A. Le Bivic et al.

    Vectorial targeting of an endogenous apical membrane sialoglycoprotein and uvomorulin in MDCK cells

    J. Cell Biol.

    (1990)
  • J.E. Lewis et al.

    E-cadherin mediates adherens junction organization through protein kinase C

    J. Cell Sci.

    (1995)
  • G. Scherer et al.

    Gene mapping on mouse chromosome 8 by interspecific crossesnew data on a linkage group conserved on human chromosome 16q

    Genomics

    (1989)
  • M. Ozawa et al.

    Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin

    J. Cell Biol.

    (1990)
  • M. Overduin et al.

    Solution structure of the epithelial cadherin domain responsible for selective cell adhesion

    Science

    (1995)
  • L. Shapiro et al.

    Structural basis of cell-cell adhesion by cadherins

    Nature

    (1995)
  • W.J. Gallin

    Evolution of the ‘classical’ cadherin family of cell adhesion molecule in vertebrates

    Mol. Biol. Evol

    (1998)
  • O. Pertz et al.

    A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation

    EMBO J.

    (1999)
  • M. Ozawa et al.

    The membrane proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively regulates adhesion activity

    J. Cell Biol.

    (1998)
  • H. Takeda et al.

    v-Src kinase shifts the cadherin-based cell adhesion from the strong to weak state and ß catenin is not required for the shift

    J. Cell Biol.

    (1995)
  • W.M. Brieher et al.

    Lateral dimerization is required for the homophilic binding activity of C-cadherin

    J. Cell Biol.

    (1996)
  • B. Angres et al.

    Mechanism for transition from initial to stable cell–cell adhesionkinetic analysis of E-cadherin-mediated adhesion using a quantitative inhibition assay

    J. Cell Biol.

    (1996)
  • C.L. Adams et al.

    Quantitative analysis of cadherin–catenin–actin reorganization during development of cell–cell adhesion

    J. Cell Biol.

    (1996)
  • Cited by (327)

    • Cancer-cell-intrinsic mechanisms regulate MDSCs through cytokine networks

      2023, International Review of Cell and Molecular Biology
    • Exercise training inhibits atherosclerosis progression and reduces VE-cadherin levels within atherosclerotic plaques in hypercholesterolemic mice

      2022, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Ca2+ binding catalyses its transformation to a more stable and functional molecule, which is involved in numerous physiological and pathophysiological procedures [6]. Thereby, VE-cadherin mediates cell signalling [7], while the loss of its function has been associated with cancer evolution and metastasis [8]. In vitro data have also proposed that VE-cadherin controls vascular permeability, leucocyte transmigration, angiogenesis and, not surprisingly, atherogenesis [9,10].

    View all citing articles on Scopus
    View full text